Company patents

Genomatica, Inc.

Genomatica, Inc. demonstrates a strong, albeit fluctuating, commitment to Fermentation & Biosynthesis, which comprises 86.7% of its portfolio and saw a 40.9% YoY increase in 2025, but a significant -58.1% decline so far in 2026. Surprisingly, while core areas like Polymer Synthesis (Polycondensation) and Pharmaceutical Preparations show a clear shifting priority with -100.0% YoY declines so far in 2026, the company is also showing an emerging focus in Acyclic / Carbocyclic Compounds, which experienced a remarkable 300.0% YoY growth in 2024, despite a -75.0% decline so far in 2026.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

113 US filings (since 2023) · 8 categories · 10 themes

Bio-derived Chemical Production

Methods for producing organic chemicals from biomass or through fermentation processes, often focusing on carbohydrates or fatty acid derivatives for food, health, or industrial applications.

Acyclic / Carbocyclic Compounds
Who else files here? →
84since 2023
+61.1%YoY
Novel Protein & Fermentation Technologies

Methods and compositions for developing new protein sources (e.g., microbial, plant-based blends) or utilizing controlled fermentation processes to create novel food products, improve nutritional profiles, or enhance specific characteristics like texture or flavor.

Foods & Beverages
Who else files here? →
60since 2023
+58.3%YoY
Bioprocess Development for Proteins

Methods and systems for the efficient and scalable production, purification, and formulation of proteins and peptides, including fermentation, chromatography, and cell-based expression systems.

Peptides & Proteins
Who else files here? →
43since 2023
+40.0%YoY
Bioprocess Optimization and Control

Developing advanced bioreactor designs, fermentation strategies, and downstream processing techniques to optimize yield, purity, and efficiency of biotechnological production.

Fermentation & Biosynthesis
Who else files here? →
20since 2023
+20.0%YoY
Industrial Organic Synthesis

Methods and apparatus for the efficient and selective production of organic compounds, including amines, acids, and esters, often involving catalytic or continuous processes and purification steps.

Acyclic / Carbocyclic Compounds
Who else files here? →
18since 2023
-16.7%YoY
Recombinant Host Engineering

Modifying microorganisms, plant cells, or animal cells through genetic engineering to enhance or enable the biosynthesis of target compounds, often involving metabolic pathway engineering.

Fermentation & Biosynthesis
Who else files here? →
12since 2023
-25.0%YoY
Sustainable Polymer Materials

Development and application of polymer compositions designed for reprocessability, recyclability, or incorporating sustainable additives, often featuring reversible bonds or bio-based components.

Polymer Synthesis (Polycondensation)
Who else files here? →
6since 2023
-33.3%YoY
Enzyme Directed Evolution

Identifying novel enzymes or modifying existing enzymes through mutagenesis and directed evolution to improve catalytic activity, substrate specificity, or stability for industrial biotransformations.

Fermentation & Biosynthesis
Who else files here? →
3since 2023
new
Urethane/Urea Polymerization

Methods for synthesizing polyurethanes and polyureas, including non-isocyanate routes, using various monomers, catalysts, and curing agents, often for foams, coatings, or adhesives.

Polymer Synthesis (Polycondensation)
Who else files here? →
3since 2023
n/a
Chemical Synthesis of Drug Intermediates

Processes and methodologies for the efficient and scalable preparation of complex heterocyclic compounds and their precursors, including specific reaction conditions, purification techniques, and intermediate compounds.

Heterocyclic Compounds (Pharma)
Who else files here? →
3since 2023
n/a

Patents

Showing 161-170 of 214

Page 17 of 22
US 11180780 B2GRANTED
C12N9/88

Organisms for the production of 1,3-butanediol

Filed:2017-06-07Pub:2021-11-23
Applicant:Genomatica, Inc.

A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2-one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl-CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.

116171822